Digestive tolerance of inulin-type fructans: a double-blind, placebo-controlled, cross-over, dose-ranging, randomized study in healthy volunteers

被引:43
作者
Bruhwyler, Jacques [3 ]
Carreer, Fabienne [3 ]
Demanet, Etienne [2 ]
Jacobs, Heidi [1 ]
机构
[1] Cosucra Grp Warcoing Sa, B-7740 Warcoing, Belgium
[2] ResearchLink Sprl, Thuin, Belgium
[3] Squarepoint Pointcarre Sprl, Ecaussinnes, Belgium
关键词
Inulin; fructan; tolerance; gastro-intestinal; healthy volunteers; HUMAN COLONIC MICROBIOTA; FECAL BIFIDOBACTERIA; DIETARY MODULATION; CHICORY INULIN; OLIGOFRUCTOSE; OLIGOSACCHARIDES; GLUCOSE; FIBER;
D O I
10.1080/09637480701625697
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Background Similar to other indigestible carbohydrates or dietary fibres, a consumption of too large quantities of inulin-type fructans may cause some digestive problems. Aim To compare the digestive tolerance of inulin-type fructans, administered during 2 weeks, at different doses. Methods Eighty-four healthy volunteers (aged 18-45 years, mean body mass index 25.1 kg/m2 and mean total fibre consumption 12 g) were included in a double-blind, placebo-controlled, randomized, cross-over study comparing Fibrulose F97 (5 and 20 g/day), Fibruline Instant (5, 10 and 20 g/day) and Fibruline XL (10 g/day) (degrees of polymerization respectively equal to 2-20, 2-60 with an average of 10, and 2-60 with an average 20) to placebo. The study was decomposed into five 2-week periods: placebo run-in, treatment 1, placebo washout, treatment 2, placebo run-out. The following symptoms were assessed using visual analogue scales: flatulence, rumbling, bloating, abdominal pain, abdominal cramps, nausea, stool frequency and stool consistency. The primary variable was the mean difference between treatment and placebo in terms of tolerance (sum of the eight visual analogue scales). Results The three products tended to increase digestive symptoms whatever the dose but the change was mild (maximum, +19 mm on the 800-mm scale) and significant (P0.001) for Fibruline Instant at 20 g/day only. At 20 g/day, a statistically significant difference between Fibruline Instant and Fibrulose F97 was demonstrated (P=0.011). There was a dose-effect relationship both for Fibrulose F97 (P0.05) and Fibruline Instant (P=0.042). All the other tendencies were non-significant. Conclusions The three different inulin-type fructans were very well tolerated.
引用
收藏
页码:165 / 175
页数:11
相关论文
共 50 条
  • [41] A randomized placebo-controlled cross-over study on the effects of anthocyanins on inflammatory and metabolic responses to a high-fat meal in healthy subjects
    Cremonini, Eleonora
    Daveri, Elena
    Iglesias, Dario E.
    Kang, Jiye
    Wang, Ziwei
    Gray, Russell
    Mastaloudis, Angela
    Kay, Colin D.
    Hester, Shelly N.
    Wood, Steven M.
    Fraga, Cesar G.
    Oteiza, Patricia, I
    REDOX BIOLOGY, 2022, 51
  • [42] B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men
    B. B. Heinisch
    G. Vila
    M. Resl
    M. Riedl
    B. Dieplinger
    T. Mueller
    A. Luger
    G. Pacini
    M. Clodi
    Diabetologia, 2012, 55 : 1400 - 1405
  • [43] A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy
    Skripak, Justin M.
    Nash, Scott D.
    Rowley, Hannah
    Brereton, Nga H.
    Oh, Susan
    Hamilton, Robert G.
    Matsui, Elizabeth C.
    Burks, A. Wesley
    Wood, Robert A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (06) : 1154 - 1160
  • [44] Liver alterations are not improved by inulin supplementation in alcohol use disorder patients during alcohol withdrawal: A pilot randomized, double-blind, placebo-controlled study
    Amadieu, Camille
    Maccioni, Luca
    Leclercq, Sophie
    Neyrinck, Audrey M.
    Delzenne, Nathalie M.
    de Timary, Philippe
    Staerkel, Peter
    EBIOMEDICINE, 2022, 80
  • [45] Testosterone Therapy in Women With Chronic Heart Failure A Pilot Double-Blind, Randomized, Placebo-Controlled Study
    Iellamo, Ferdinando
    Volterrani, Maurizio
    Caminiti, Giuseppe
    Karam, Roger
    Massaro, Rosalba
    Fini, Massimo
    Collins, Peter
    Rosano, Giuseppe M. C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (16) : 1310 - 1316
  • [46] Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled study
    Velmurugan, Shanti
    Gan, Jasmine Ming
    Rathod, Krishnaraj S.
    Khambata, Rayomand S.
    Ghosh, Suborn M.
    Hartley, Amy
    Van Eijl, Sven
    Sagi-Kiss, Virag
    Chowdhury, Tahseen A.
    Curtis, Mike
    Kuhnle, Gunter G. C.
    Wade, William G.
    Ahluwalia, Amrita
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2016, 103 (01) : 25 - 38
  • [47] Dairy proteins and the response to pneumovax in senior citizens: a randomized, double-blind, placebo-controlled pilot study
    Freeman, Samara L.
    Fisher, Laura
    German, J. Bruce
    Leung, Patrick S.
    Prince, Harry
    Selmi, Carlo
    Naguwa, Stanley M.
    Gershwin, M. Eric
    FOODS FOR HEALTH IN THE 21ST CENTURY: A ROAD MAP FOR THE FUTURE, 2010, 1190 : 97 - 103
  • [48] The effects of inulin supplementation on clinical indices, oxidative stress and inflammatory biomarkers in women with migraine: A double-blind, placebo-controlled, randomized trial
    Vajdi, Mahdi
    Khorvash, Fariborz
    Askari, Gholamreza
    JOURNAL OF FUNCTIONAL FOODS, 2024, 121
  • [49] Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study
    Sasaki, Makoto
    Ogasawara, Naotaka
    Funaki, Yasushi
    Mizuno, Mari
    Iida, Akihito
    Goto, Chiho
    Koikeda, Satoshi
    Kasugai, Kunio
    Joh, Takashi
    BMC GASTROENTEROLOGY, 2013, 13
  • [50] Effects of heat-killed Lactobacillus casei subsp casei 327 intake on defecation in healthy volunteers: a randomized, double-blind, placebo-controlled, parallel-group study
    Saito, Yuhi
    Mihara, Toshihiro
    Oki, Mamoru
    Kumagai, Takehisa
    BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH, 2018, 37 (03): : 59 - 65